The Western blot analysis was carried out as described by Zhu et al (Zhu, et al. 2014 (link)). Primary antibodies for p-AKT (#9271), total-AKT (#9272), PTEN (#9552), CDK4 (#2906), CDK6 (#3136), p-RB (#9307), MMP7 (#3801), and GAPDH (#2118) were purchased from Cell Signaling Technology (Danvers, MA). The p21 primary antibody (sc-6246), Rb (sc-50), and MMP2 (sc-10736) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Primary antibody against ERBB2 (RB-103-P0) was purchased from Neomarkers (Fremont, CA). Antibodies were used at a concentration recommended by the manufacturers. For control of protein loading, the blot was probed with the antibody against GAPDH.